| Biomarker ID | 1018 |
| PMID | 23171880 |
| Year | 2012 |
| Biomarker | sICAM-1 |
| Biomarker Basis | Concentration Based (ng/ml) |
| Biomolecule | Protein |
| Source | Plasma |
| Subjects | Humans |
| Regulation | Upregulated in PCa (PCa: 245.2 , Normal: 240.3) |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 1.86 (95% CI: 1.06 - 3.26) |
| Effect on Pathways | Inflammation and Endothelial |
| Experiment | PCa Vs Controls |
| Type of Biomarker | Diagnostic |
| Cohort | 156 prostate cancer cases along with 1024 controls were used for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.005 |
| Method Used | Immunometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | sICAM-1 |